1. Home
  2. CORT vs MTN Comparison

CORT vs MTN Comparison

Compare CORT & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • MTN
  • Stock Information
  • Founded
  • CORT 1998
  • MTN 1997
  • Country
  • CORT United States
  • MTN United States
  • Employees
  • CORT N/A
  • MTN N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • MTN Services-Misc. Amusement & Recreation
  • Sector
  • CORT Health Care
  • MTN Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • MTN Nasdaq
  • Market Cap
  • CORT 7.6B
  • MTN 6.1B
  • IPO Year
  • CORT N/A
  • MTN 1997
  • Fundamental
  • Price
  • CORT $71.66
  • MTN $143.71
  • Analyst Decision
  • CORT Strong Buy
  • MTN Hold
  • Analyst Count
  • CORT 4
  • MTN 10
  • Target Price
  • CORT $139.00
  • MTN $186.50
  • AVG Volume (30 Days)
  • CORT 640.1K
  • MTN 510.6K
  • Earning Date
  • CORT 10-29-2025
  • MTN 09-25-2025
  • Dividend Yield
  • CORT N/A
  • MTN 6.18%
  • EPS Growth
  • CORT N/A
  • MTN 6.60
  • EPS
  • CORT 1.11
  • MTN 7.74
  • Revenue
  • CORT $716,080,000.00
  • MTN $2,958,444,000.00
  • Revenue This Year
  • CORT $30.62
  • MTN $3.77
  • Revenue Next Year
  • CORT $37.68
  • MTN $3.87
  • P/E Ratio
  • CORT $64.27
  • MTN $18.55
  • Revenue Growth
  • CORT 25.71
  • MTN 2.38
  • 52 Week Low
  • CORT $34.34
  • MTN $129.85
  • 52 Week High
  • CORT $117.33
  • MTN $199.45
  • Technical
  • Relative Strength Index (RSI)
  • CORT 53.12
  • MTN 31.12
  • Support Level
  • CORT $67.32
  • MTN $156.20
  • Resistance Level
  • CORT $72.52
  • MTN $160.75
  • Average True Range (ATR)
  • CORT 1.92
  • MTN 3.95
  • MACD
  • CORT 0.14
  • MTN -1.62
  • Stochastic Oscillator
  • CORT 64.27
  • MTN 0.38

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: